UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000048000
Receipt number R000054719
Scientific Title Suppressive effects of orally ingested tomato-derived dietary fibers on postprandial blood triglyceride levels: a systematic review with meta-analysis.
Date of disclosure of the study information 2023/12/31
Last modified on 2023/06/13 11:37:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Suppressive effects of orally ingested tomato-derived dietary fibers on postprandial blood triglyceride levels: a systematic review with meta-analysis.

Acronym

Suppressive effects of tomato-derived dietary fibers on postprandial blood triglyceride levels: a systematic review.

Scientific Title

Suppressive effects of orally ingested tomato-derived dietary fibers on postprandial blood triglyceride levels: a systematic review with meta-analysis.

Scientific Title:Acronym

Suppressive effects of tomato-derived dietary fibers on postprandial blood triglyceride levels: a systematic review.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether orally ingested tomato-derived dietary fibers suppress postprandial blood triglyceride levels in healthy adults.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Postprandial blood triglyceride levels, delta blood triglyceride levels, area under the curve calculated based on the change of delta blood triglyceride levels, the peak value of delta blood triglyceride levels

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(PICOS)
Participant:
Healthy adults without illness (excluding pregnant women (including those planning to become pregnant) and lactating women)

Intervention:
Oral intake of test food containing tomato-derived dietary fiber (regardless of the form of intake)

Comparison:
Oral intake of test food without tomato-derived dietary fibers, or no intervention

Outcome measurement:
Postprandial blood triglyceride levels, delta blood triglyceride levels, area under the curve calculated based on the change of delta blood triglyceride levels, the peak value of delta blood triglyceride levels

Study design:
Randomized controlled parallel trials (RCT-P), randomized controlled crossover trials (RCT-C), quasi- randomized controlled parallel trials (qRCT-P), quasi randomized controlled crossover trials (qRCT-C), non-randomized controlled parallel trials (nonRCT-P), non-randomized controlled crossover trials (nonRCT-C), and non-randomized controlled trials

(Language)
Eligibility is not restricted by language.

Key exclusion criteria

Exclude proceedings and unpublished studies which don't give us enough research details, and other gray documents that are difficult to verify.

Target sample size



Research contact person

Name of lead principal investigator

1st name Takuro
Middle name
Last name Inoue

Organization

KAGOME CO., LTD.

Division name

Innovation Division

Zip code

3292762

Address

17 Nishitomiyama, Nasushiobara-shi, Tochigi

TEL

0287-36-2935

Email

g167_0@kagome.co.jp


Public contact

Name of contact person

1st name Kazutaka
Middle name
Last name Yoshida

Organization

KAGOME CO., LTD.

Division name

Innovation Division

Zip code

3292762

Address

17 Nishitomiyama, Nasushiobara-shi, Tochigi

TEL

0287-36-2935

Homepage URL


Email

g167_0@kagome.co.jp


Sponsor or person

Institute

KAGOME CO., LTD.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kagome research ethics committee

Address

3-21-1 Nihonbashihamacho, Chuo-ku, Tokyo, 103-8461

Tel

03-5623-8501

Email

toshika_okuni@kagome.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

202

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2022 Year 06 Month 07 Day

Date of IRB

2022 Year 06 Month 08 Day

Anticipated trial start date

2022 Year 06 Month 09 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Research papers will be searched for 8 databases from the beginning of each database to the search date by two reviewers. To increase the comprehensiveness, the studies whose existence has been revealed by hand search, requotation, or other methods will be added to the review.

Screening and data extraction based on eligibility criteria (PICOS) will be conducted independently by two reviewers. Disagreements and uncertainties will be resolved by discussion between the reviewers or final decision by another reviewer

Assessment of the quality and evaluation of the indirectness of articles will be conducted independently by two reviewers. A full quality appraisal of these papers will be made using modified check list (13 items) of Cochrane Handbook for interventional trials. Disagreements and uncertainties will be resolved by discussion between the reviewers or final decision by another reviewer The agreement rate and the kappa coefficient will be calculated to determine the degree of agreement. Studies evaluated as having a high risk of bias will not be adopted.

A meta-analysis will be performed using EZR or RevMan by a reviewer only in the absence of heterogeneity. Studies with missing or uncertain data will be excluded if no data is available by contacting the author. If not suitable for integration, a qualitative assessment will be carried out. Estimated heterogeneity and publication bias will be assessed from I square value in Forest plot and Funnel plot, respectively. Sensitivity analysis and subgroup analysis will be performed as necessary.

Imprecision will be assessed based on the total number of participants in all included studies.

Inconsistency will be evaluated for the I square value and by statistical test for heterogeneity of effect estimates in a meta-analysis. If a meta-analysis cannot be performed, inconsistency will be assessed from the percentage of studies that have had a significant effect.


Management information

Registered date

2022 Year 06 Month 09 Day

Last modified on

2023 Year 06 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054719


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name